"10.1371_journal.pone.0076325","plos one","2013-10-01T00:00:00Z","Kutralanathan Renganathan; Jiayin Gu; Mary E Rayborn; John S Crabb; Robert G Salomon; Robert J Collier; Michael A Kapin; Carmelo Romano; Joe G Hollyfield; John W Crabb","Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America; Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America; Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, United States of America; Retina Research, Novartis Institutes for Biomedical Research, Fort Worth, Texas, United States of America; Departments of Ophthalmology and Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, United States of America","Conceived and designed the experiments: JWC RGS RJC MAK CR JGH. Performed the experiments: KR JG MER RJC. Analyzed the data: JWC JGH KR JG MER JSC. Contributed reagents/materials/analysis tools: RGS. Wrote the manuscript: JWC JGH RJC RGS.","This study was partly funded by Alcon Research Ltd. AL-8309A is being developed by Alcon Research, Ltd.  Robert J. Collier, Michael A. Kapin and Carmelo Romano are employed by Novartis Institutes for Biomedical Research. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","10","Kutralanathan Renganathan","KR",10,TRUE,6,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
